Digestive output — acid, enzymes & bile

What actually decides this outcome, in order of size

Digestion is a sequence of secretions, each of which enables the next. Low output at any step produces symptoms downstream of it, and the same secretions are damaging in the wrong place. Ranked by how much of the outcome each factor owns:

1. What is actually suppressing acid, which is usually a prescription rather than aging. Proton pump inhibitors are among the most widely used drugs there are, and the model experiment for this page used pharmacologically induced hypochlorhydria: betaine hydrochloride re-acidified the stomach in healthy volunteers with rabeprazole-induced hypochlorhydria Yago 2013. If a drug is causing it, the conversation is with the prescriber before it is with a supplement.
2. WHETHER THE PROBLEM IS TOO LITTLE OR TOO MUCH, BECAUSE THE TWO PRESENT ALIKE AND THE TREATMENTS ARE OPPOSITE. Reflux, burning and fullness after meals are produced by both low and high acid states, and Betaine HCl taken into an ulcer, an erosive esophagitis or alongside an anti-inflammatory drug is the wrong direction applied confidently. This is the sign problem on this page and it is the reason the ordering below starts with exclusion rather than with a product.
3. Pancreatic enzyme output, where the therapeutic version is a licensed drug rather than a supplement. Pancrelipase has prescription-grade evidence in exocrine pancreatic insufficiency due to chronic pancreatitis Whitcomb 2010. The dose-related risk at the other end is documented too: high-dose pancreatic enzyme supplements were linked to fibrosing colonopathy in children with cystic fibrosis FitzSimmons 1997. More is not better here either.
4. Bile flow and where the bile ends up, which is the most double-edged item on the page. Bile acids are required for fat and fat-soluble vitamin absorption, and they are also cytotoxic and have been examined as carcinogens in human gastrointestinal cancers Bernstein 2005, with deoxycholate specifically assessed Bernstein 2011. Bile acid malabsorption has its own mechanisms, treatment literature Eusufzai 1995 and prevalence and response data Ruiz-Campos 2019 — and in that condition, adding bile makes the diarrhea worse.
5. Whether a choleretic is the right tool, which has real trial data. Artichoke leaf extract has a randomized trial in functional dyspepsia Holtmann 2003, an irritable bowel syndrome trial Bundy 2004, a classical choleresis study Kirchhoff 1994 and a lipid-lowering meta-analysis Sahebkar 2018. That is a better evidence base than most of this shelf.
6. Whether the deficit is severe enough to need replacement rather than stimulation. Conjugated bile acid replacement has been studied in short-bowel syndrome Gruy-Kapral 1999 Heydorn 1999, which is a clinical setting and the correct reference point for what genuine bile insufficiency looks like.

The order to run these in, and what has to be true first

Exclude the conditions in which these products are harmful, then match the product to the step that is failing, then check absorption rather than symptoms.

1. Exclusion first, because this is the page where the wrong answer hurts. Anybody with an ulcer history, current or planned anti-inflammatory use, unexplained weight loss, vomiting, difficulty swallowing, or blood in stool needs an assessment before any of this.
2. Baseline absorption bloods, which are the objective half of this page. Complete Blood Count (CBC) with Differential with Ferritin, Vitamin B12 and Folate, Serum, plus Vitamin D (25-Hydroxy) and Vitamin A as the fat-soluble read-outs, and a Comprehensive Metabolic Panel (CMP) with GGT (Gamma-Glutamyl Transferase). Malabsorption shows here long before it shows in a symptom that is specific.
3. Digestive Enzymes as the low-risk first trial. Broad spectrum, taken with meals, and a blend of this shape is a documented product category rather than a bespoke intervention NIH DSLD record 2026.
4. Betaine HCl only after the exclusions, and understood as a re-acidifier. Its measured effect is gastric re-acidification in an induced low-acid state Yago 2013, which is a specific claim. Burning on it is a stop signal rather than a titration signal.
5. Pancreatic Enzymes if the picture is fatty, floating, difficult-to-flush stool with weight loss. That presentation is a medical one; the licensed product has the evidence Whitcomb 2010 and the dose ceiling has a documented reason FitzSimmons 1997.
6. Artichoke Leaf Extract and Dandelion Root are the choleretic step and have the best botanical evidence here Holtmann 2003 Bundy 2004 Kirchhoff 1994 Sahebkar 2018. They stimulate bile flow rather than supplying bile, which is the gentler direction of the two.
7. Ox Bile supplies bile acids directly and is the item to be most careful with. Useful after gallbladder removal or with genuine insufficiency Gruy-Kapral 1999 Heydorn 1999; actively wrong in bile acid malabsorption, where the problem is bile reaching the colon Eusufzai 1995 Ruiz-Campos 2019. TUDCA is a different molecule with a hepatocyte-protection argument covered at Hepatocyte protection & liver function.
8. DAO (Diamine Oxidase) is for a specific hypothesis and Bromelain, Ginger, Fennel and Betaine Anhydrous (TMG) are the adjunct shelf. Diamine oxidase addresses dietary histamine rather than digestion; ginger and fennel act on motility and gas; betaine anhydrous is a methyl donor and is not the same molecule as betaine hydrochloride, which is the single most common confusion on this page.

What gets bought for this that cannot move it

The category that fails structurally is bile supplementation in bile acid malabsorption. That condition has a described mechanism and treatment literature Eusufzai 1995 and a systematic review of its prevalence and response to treatment Ruiz-Campos 2019. The presenting symptom is loose, urgent stool after eating — which reads on a symptom checklist as poor fat digestion, the exact indication Ox Bile is sold for. Adding bile acids delivers more of the thing already reaching the colon. The treatment is a sequestrant, which is the opposite intervention, and the two presentations are separated by an assessment rather than by a supplement trial.

The direction failure at the top of the tract is the same shape. Betaine HCl re-acidifies Yago 2013. In somebody whose burning comes from acid reaching the esophagus rather than from too little of it, that is the wrong sign, and it is being self-prescribed against a symptom that both states produce. Anybody on an anti-inflammatory drug, with an ulcer history, or with alarm features is in the group where this stops being a wasted purchase and becomes a harm.

And bile is not a benign substance to increase indefinitely. Bile acids have been examined as carcinogens in human gastrointestinal cancers Bernstein 2005, with deoxycholate assessed specifically Bernstein 2011. That is a reason to treat a measured deficit rather than to run a bile product permanently because digestion feels better on it — the same logic that puts a ceiling on enzyme dosing FitzSimmons 1997.

If the goal underneath is different, so is the page. If the problem is bloating that builds through the day with altered bowel habit, Overgrowth, dysbiosis & antimicrobials. If it is pain and urgency with normal absorption, Motility, IBS & the brain-gut axis. If it is barrier and mucosal integrity, Barrier integrity & mucosal repair. If it is the microbiome, Microbiome composition & prebiotic substrate. And weight loss, blood, vomiting or difficulty swallowing is an assessment this week rather than a supplement decision.

How you would know it was working, on a real read-out and a real timescale

This page makes two predictions. Absorption markers move before symptoms settle, so Ferritin and Vitamin B12 are the honest read-out rather than how full somebody feels after dinner; and if six weeks of an enzyme or acid product has changed nothing measurable, the step being supplemented was not the step that was failing.

• Complete Blood Count (CBC) with Differential with Ferritin, Vitamin B12 and Folate, Serum at baseline and 12 weeks. Iron and B12 absorption both depend on gastric acid, so these are the closest thing to a functional acid test available outside a specialist unit Yago 2013. Twelve weeks because red cell indices and stores move on that scale.
• Vitamin D (25-Hydroxy) and Vitamin A at baseline and six months. Fat-soluble vitamin status is the read-out for bile and lipase adequacy, and it is the measurement that separates a real fat-digestion problem from a sensation of heaviness.
• Comprehensive Metabolic Panel (CMP) with GGT (Gamma-Glutamyl Transferase) at baseline and 12 weeks. Bilirubin, alkaline phosphatase and GGT together point at biliary flow, and a rise on a choleretic or a bile product is a reason to stop rather than to continue Kirchhoff 1994.
• Lipase and Amylase once if the picture includes fatty stool or weight loss. These do not diagnose exocrine insufficiency on their own, and an abnormal result redirects the whole page toward a clinician and a licensed enzyme Whitcomb 2010.
• A written symptom and stool diary for two weeks before and six weeks after any single change. One change at a time, because the products on this page act at different steps and a stack tells you nothing about which step was failing.

What will fool you. Meal composition changes symptoms more than any product here, and it usually changes at the same time somebody starts a supplement. Burning on Betaine HCl is a stop signal, not evidence of a dose that is nearly right Yago 2013. Loose stool improving on a low-fat week looks like an enzyme working. Bile acid malabsorption responds to the opposite treatment from the one this page's products deliver Ruiz-Campos 2019. Betaine Anhydrous (TMG) and betaine hydrochloride share a name and do different jobs. And a blend with eight components that helps tells you nothing about which component did it NIH DSLD record 2026.

Sources read for these sections

• Yago MR. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria. Mol Pharm 2013 · PMID 23980906
• Whitcomb DC. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol 2010 · PMID 20502447
• FitzSimmons SC. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997 · PMID 9113931
• Bernstein H. Bile acids as carcinogens in human gastrointestinal cancers.. Mutat Res 2005 · PMID 15652226
• Bernstein C. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 2011 · PMID 21267546
• Eusufzai S. Bile acid malabsorption: mechanisms and treatment. Dig Dis 1995 · PMID 8542666
• Ruiz-Campos L. Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy.. Aliment Pharmacol Ther 2019 · PMID 30585336
• Holtmann G. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.. Aliment Pharmacol Ther 2003 · PMID 14653829
• Bundy R. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis.. J Altern Complement Med 2004 · PMID 15353023
• Kirchhoff R. Increase in choleresis by means of artichoke extract.. Phytomedicine 1994 · PMID 23195882
• Gruy-Kapral C. Conjugated bile acid replacement therapy for short-bowel syndrome.. Gastroenterology 1999 · PMID 9869597
• Heydorn S. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.. Scand J Gastroenterol 1999 · PMID 10499484
• Sahebkar A. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Crit Rev Food Sci Nutr 2018 · PMID 28609140
• NIH DSLD record. Bio-Gest (Thorne), label record marked off-market 20 February 2024: per 2 capsules betaine hydrochloride 480 mg, L-glutamic acid hydrochloride 480 mg, pancreatin 140 mg declaring lipase 2,450 USP units, ox bile concentrate 80 mg and porcine pepsin 70 mg. NIH Dietary Supplement Label Database, DSLD ID 291774, retrieved 2026